Am completely undecided on this one now. Not sure if an early entry is worth it or a wait and see approach. Conservative profile so the default is wait and see but I suspect this might leave an opportunity wanting.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025